AZ divests migraine drug to Grünenthal

7th June 2017 Uncategorised 0

AstraZeneca has sold global rights (ex Japan) for its migraine drug Zomig to Grünenthal, as it continues to shed products outside of its area of strategic focus.

More: AZ divests migraine drug to Grünenthal
Source: News